4. 4
• Our cognitive abilities appear to peak in our
20s and thereafter, there is slow and subtle
decline
• Perhaps the earliest cognitive ability to decline
is processing speed
• People are not inclined to notice or be
concerned about changes to their cognition
before their 40s.
4
Normal aging
5. 5
• Memory
The most common cognitive complaint as we age
Disproportionate decline in short-term memory (the
ability to recall new information shortly after it is
presented)
Whereas younger people tend to remember recent
events more easily than remote events, older people tend
to remember remote events more readily than recent
events
5
Normal aging
6. 6
• Memory
Do not tend to lose autobiographical
information
Memory of factual information and general
word knowledge is relatively resistant to aging
Do not tend to lose learned skills, but rate of
new skill learning in older adults is slower
6
Normal aging
7. 7
• Attention
Decline in the ability to filter nonessential or irrelevant
information when selective attention is required
Performance decline for tasks requiring divided attention
Sustained attention is relatively unaffected
7
Normal aging
8. 8
• Language
Increased difficulty retrieving names of
people, places, and objects (“tip of the tongue”
phemonenon)
Rate of verbal output (fluency) declines with
age
8
Normal aging
9. 9
• Executive function
Effectively allows us to plan and organize our way
through the day
Requires intact attention, mental manipulation of
learned material, abstraction, and adaptation
As we age, there is a relative decline in mental
flexibility and tendency towards perseveration
We develop an increasingly rigid or concrete
approach to reasoning
9
Normal aging
10. 10
Outline
iii. A quick review of Alzheimer’s disease
i. What do you expect, I’m 82 years-old?
ii. A clinician’s approach to cognitive
complaints
11. 11
Clinical assessment
• History is paramount
• Always helpful to obtain information from
an independent observer who knows the
patient well as persons with dementia are
often unaware of their impairments
• Important to understand the rapidity of
onset and decline. An insidiously
developing process is more often typical of
dementia.
11
12. 12
• Cognitive complaints (e.g. memory, language,
visuospatial function)
• Psychiatric symptoms (apathy, depression, anxiety,
insomnia, fearfulness, paranoia, hallucinations)
• Personality changes (changes to temper,
impulsiveness, disinterest)
• Problem behaviors (wandering, agitation, out of bed
at night)
12
Clinical assessment
13. 13
• In addition to cognitive complaints, your clinician wants
to know if there has been a functional impairment
• Instrumental activities of daily living (IADLs)
Housework (e.g. housekeeping, cooking)
Adherence to medications
Managing money, paying bills
Shopping
Telephone / communication
Transportation
13
Clinical assessment
14. 14
• After acquiring the history (subjective), your
clinician will make both a
neuropsychological and a physical
assessment (objective)
14
Clinical assessment
16. 16
• Determinations
Are the cognitive complaints disproportionate to age?
Could the cognitive complaints be a consequence of a
non-neurologic condition (e.g. medical illness,
medication effect)?
Are the history, neuropsychological examination, and
physical examination concordant and consistent with a
syndromic dementia (e.g. Alzheimer’s disease)?
16
Clinical assessment
17. 17
• As a matter of standard practice, we routinely
look for relatively common causes of “reversible
dementia”
B12 deficiency
Thyroid dysfunction
Anatomical changes (MRI or CT brain)
• Additional tests may be included as clinically
indicated
17
Clinical assessment
22. 22
• Hallmark and early feature of typical
Alzheimer’s disease is a decline in verbal
and visual “episodic memory” (memories tied
to experiences, e.g. what you ate for dinner)
• Progressive decline in other
neuropsychological domains (e.g. executive
function, language, visuospatial) and ability
to carry out IADLs
22
Alzheimer’s disease
23. 23
• Accumulation of extraneuronal amyloid
plaques (amyloid beta) and intraneuronal
neurofibrillary tangles (tau)
• Neuronal death
23
Alzheimer’s disease
25. 25
• Mild cognitive impairment (MCI)
Subjective decline in memory or other cognitive
dysfunction
Greater than expected for age
No functional impairment (IADLs)
• Approx 80% of individuals with amnestic MCI
will convert to Alzheimer’s disease within 6
years (a “preclinical” state)
25
The “gray zone”
“g
28. 28
• Sirven, IJ and Malamut, BL. (2008). Clinical
Neurology of the Older Adult. Philadelphia:
Lippincott Williams & Wilkins.
• 2012 Alzheimer’s Disease Facts and Figures.
Alzheimer’s Association
( http://www.alz.org/downloads/facts_figures_2012.
pdf )
• Video: Inside the brain: unraveling the mystery of
Alzheimer’s disease. National Institute on Aging
28
References